Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

"YOUR WELCOME" with Michael Malice

Martin Shkreli – Episode #257

03 May 2023

Description

Michael Malice (“YOUR WELCOME”) welcomes biotech founder, Martin Shkreli, onto the show to talk about the Daraprim controversy, how hard it is to tell your side of the story when American media has already painted you as the enemy, and the one federal agency Martin surprisingly thinks is good at what they do.  Martin and Michael also discuss his time in prison, and the one joke that led to his bail being revoked.  linktr.ee/martinshkreli instagram.com/martinshkreli15/ youtube.com/channel/UCjYKsjt-7EDU78KEcVbhYnQ Order THE WHITE PILL: http://whitepillbook.com/ Order THE ANARCHIST HANDBOOK: https://www.amzn.com/B095DVF8FJ Order THE NEW RIGHT: https://amzn.to/2IFFCCu Order DEAR READER: https://t.co/vZfTVkK6qf?amp=1   https://twitter.com/michaelmalice https://instagram.com/michaelmalice  https://malice.locals.com https://youtube.com/michaelmaliceofficial    Intro song: "Out of Reach" by Legendary House Cats https://thelegendaryhousecats.bandcamp.com/   The newest episode of "YOUR WELCOME" releases on iTunes and YouTube every Thursday! Please subscribe and leave a review.   This week's sponsors: 4Patriots – Survival Food Kits: 4Patriots.com, promo code: MALICE (10% off) Fum - The Natural Alternative: tryfum.com, promo code: MALICE (10% off) Patriot Gold Group – No Fee IRA: Call 888-505-9845 or visit malicegold.com (Free investor guide) PlutoTV – Streaming TV: Pluto.tv Progressive – Name Your Price Tool: progressive.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.